Bone Biologics Corp Warrants (BBLGW)

• Market cap: $18.3M
• 5 days: 40.7%
• 1 month: -34.12%
• 3 months: -53.33%
• 6 months: -72%
• Year to date: -61.9%
• 1 year: -46.1%
• 5 years: -84.31%
• 10 years: -84.31%
• Sector: Healthcare
• Industry: Biotechnology

About: Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Employees: 2